Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in Greece.
Souliotis KyriakosChristina GolnaChara KaniSofia NikolaidiDimitrios BoumpasPublished in: PloS one (2019)
Real world, big data analysis confirms that the major driver of RA pharmaceutical cost is, as expected, the cost of treatment with biologics. It is critical to be able to match this cost to the treatment outcome it produces to ensure an optimal, no-waste, evidence-based allocation of healthcare resources to need.